CDT Equity (CDT) Gains from Investment Securities (2023 - 2025)
CDT Equity's (CDT) quarterly Gains from Investment Securities came in at -$1000.0 in Q4 2025, up 99.03% YoY from -$502.44 in Q4 2024, and up 85.71% on a QoQ basis from -$7000.0 in Q2 2025.
CDT Equity (CDT) Gains from Investment Securities (2023 - 2025) Analysis & Trends
CDT Equity (CDT) has 3 years of Gains from Investment Securities data on file, last reported at -$1000.0 in Q4 2025.
- Quarterly Gains from Investment Securities rose 99.03% year-over-year to -$1000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$138000.0 (up 37.56% YoY) and the FY2025 annual result came in at -$138000.0, up 37.56% from the prior year.
- Gains from Investment Securities rose to -$1000.0 in Q4 2025, from -$7000.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $50000.0 in Q4 2023 to a low of -$131000.0 in Q3 2023.
- A 3-year average of -$48888.9 and a median of -$19000.0 in 2024 frame the typical range for Gains from Investment Securities.
- The widest YoY moves for Gains from Investment Securities: up 99.03% in 2025, down 584.21% in 2025.
- Tracing CDT's Gains from Investment Securities over 3 years: stood at $50000.0 in 2023, then plunged by 306.0% to -$103000.0 in 2024, then jumped by 99.03% to -$1000.0 in 2025.
- The last three Gains from Investment Securities figures came in at -$1000.0 (Q4 2025), -$7000.0 (Q2 2025), and -$130000.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | CDT Equity | 1.55 Mn | 1.55 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1,000.00 |
| Dec 31, 2025 | -1,000.00 |
| Jun 30, 2025 | -7,000.00 |
| Jun 30, 2025 | -7,000.00 |
| Mar 31, 2025 | -130,000.00 |
| Mar 31, 2025 | -130,000.00 |
| Dec 31, 2024 | -103,000.00 |
| Dec 31, 2024 | -103,000.00 |
| Sep 30, 2024 | -8,000.00 |
| Sep 30, 2024 | -8,000.00 |
| Jun 30, 2024 | -91,000.00 |
| Jun 30, 2024 | -91,000.00 |
| Mar 31, 2024 | -19,000.00 |
| Mar 31, 2024 | -19,000.00 |
| Dec 31, 2023 | 50,000.00 |
| Dec 31, 2023 | 50,000.00 |
| Sep 30, 2023 | -131,000.00 |
| Sep 30, 2023 | -131,000.00 |